alpha-aminopyridine has been researched along with Liver Steatosis in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (33.33) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (66.67) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Arner, EN; Brekken, RA; Cruz, VH; Scherer, PE; Wynne, KW | 1 |
Chang, L; Chiang, SH; Decker, SJ; Downes, M; Evans, RM; Hochberg, I; Larsen, MJ; Li, P; Liddle, C; Mowers, J; Oh, D; Olefsky, JM; Reilly, SM; Rubin, JR; Saltiel, AR; Uhm, M; White, NM; Yu, RT | 1 |
Desager, JP; Geubel, AP; Horsmans, Y; Leclercq, I; Pauwels, S | 1 |
3 other study(ies) available for alpha-aminopyridine and Liver Steatosis
Article | Year |
---|---|
Loss of Tbk1 kinase activity protects mice from diet-induced metabolic dysfunction.
Topics: Aminopyridines; Animals; Body Weight; Diet, High-Fat; Disease Models, Animal; Fatty Liver; I-kappa B Kinase; Insulin; Insulin Resistance; Male; Metabolic Diseases; Mice; Mice, Inbred C57BL; Mice, Knockout; Obesity; Phosphorylation; Protein Serine-Threonine Kinases; Signal Transduction; Weight Loss | 2018 |
An inhibitor of the protein kinases TBK1 and IKK-ɛ improves obesity-related metabolic dysfunctions in mice.
Topics: Aminopyridines; Animals; Anti-Allergic Agents; Anti-Obesity Agents; Cell Line; Diet, High-Fat; Energy Metabolism; Enzyme Activation; Fatty Liver; Glucose Metabolism Disorders; I-kappa B Kinase; Insulin Resistance; Intra-Abdominal Fat; Male; Mice; Mice, Inbred C57BL; Mice, Obese; NF-kappa B; Obesity; Oxygen Consumption; Protein Serine-Threonine Kinases; Weight Loss | 2013 |
Dietary restriction of energy and sugar results in a reduction in human cytochrome P450 2E1 activity.
Topics: Adult; Alanine Transaminase; Aminopyridines; Area Under Curve; Aspartate Aminotransferases; Breath Tests; Chlorzoxazone; Cytochrome P-450 CYP2E1; Dietary Sucrose; Fatty Liver; Feeding Behavior; Female; Humans; Liver; Liver Function Tests; Male; Middle Aged; Ultrasonography | 1999 |